Add to ORKGRegulatory Europeanization, national autonomy and regulatory effectiveness: Marketing authorization for pharmaceuticals MPIfG discussion paper, No. 02/6 Provided in Cooperation with
This article analyses the setting of global pharmaceutical standards in the International Council fo...
In the EU, a medicinal product needs a marketing authorization (MA) to be placed on the market. The ...
This article analyses the setting of global pharmaceutical standards in the International Council fo...
"The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
'The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achi...
The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achi...
"The paper explores the successful European scheme for the authorisation of pharmaceuticals within t...
Regulatory Affairs in the pharmaceutical business is coping with all aspects of state affairs and to...
Protection of innovation in the pharmaceutical industry has traditionally been realised through prot...
The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achi...
This article examines the development of mutual recognition of marketing authorizations for pharmace...
This article analyses the setting of global pharmaceutical standards in the International Council fo...
This article examines the development of mutual recognition of marketing authorizations for pharmace...
This article examines the development of mutual recognition of marketing authorizations for pharmace...
This article analyses the setting of global pharmaceutical standards in the International Council fo...
In the EU, a medicinal product needs a marketing authorization (MA) to be placed on the market. The ...
This article analyses the setting of global pharmaceutical standards in the International Council fo...
"The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
'The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achi...
The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achi...
"The paper explores the successful European scheme for the authorisation of pharmaceuticals within t...
Regulatory Affairs in the pharmaceutical business is coping with all aspects of state affairs and to...
Protection of innovation in the pharmaceutical industry has traditionally been realised through prot...
The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achi...
This article examines the development of mutual recognition of marketing authorizations for pharmace...
This article analyses the setting of global pharmaceutical standards in the International Council fo...
This article examines the development of mutual recognition of marketing authorizations for pharmace...
This article examines the development of mutual recognition of marketing authorizations for pharmace...
This article analyses the setting of global pharmaceutical standards in the International Council fo...
In the EU, a medicinal product needs a marketing authorization (MA) to be placed on the market. The ...
This article analyses the setting of global pharmaceutical standards in the International Council fo...